Received Feb 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y017062 | — |
No additional AE; Customer called to report TE. Vaccines were administered to patients.; This spontaneous report was received from a medical assistant and refers to a specific patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-Feb-2026, the patient was vaccinated with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #Y017062 with valid expiration date reported as 11-Oct-2026) (dose, route of administration and vaccination site were not reported) administered for prophylaxis. The vaccine was reconstituted with sterile diluent, solution for injection (lot # and expiration date were not reported). A temperature excursion was reported (temperature: -14°C up to -10°C (-13.6 C): time frame: for 2 hours 5 minutes 0 seconds; previous temperature excursion: no) (product storage error). Symptoms were not reported. No additional adverse event (AE) and no product quality complaint (PQC) was reported (no adverse event). This was one of several reports received from the same reporter.
Merck sterile diluent